london rheumatology limited Company Information
Company Number
07052166
Website
www.londonrheumatology.co.ukRegistered Address
62 stakes road, waterlooville, PO7 5NT
Industry
General medical practice activities
Telephone
02084043937
Next Accounts Due
July 2024
Group Structure
View All
Shareholders
john stewart axford 70%
carolyn wyndham axford 30%
london rheumatology limited Estimated Valuation
The estimated valuation range for london rheumatology limited, derived from financial data as of October 2022 and the most recent industry multiples, is between £157.7k to £2m
london rheumatology limited Estimated Valuation
The estimated valuation range for london rheumatology limited, derived from financial data as of October 2022 and the most recent industry multiples, is between £157.7k to £2m
london rheumatology limited Estimated Valuation
The estimated valuation range for london rheumatology limited, derived from financial data as of October 2022 and the most recent industry multiples, is between £157.7k to £2m
Get a detailed valuation report, edit figures and unlock valuation multiples.
London Rheumatology Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
London Rheumatology Limited Overview
London Rheumatology Limited is a live company located in waterlooville, PO7 5NT with a Companies House number of 07052166. It operates in the general medical practice activities sector, SIC Code 86210. Founded in October 2009, it's largest shareholder is john stewart axford with a 70% stake. London Rheumatology Limited is a established, micro sized company, Pomanda has estimated its turnover at £278.2k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
London Rheumatology Limited Health Check
Pomanda's financial health check has awarded London Rheumatology Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
5 Weak
Size
annual sales of £278.2k, make it smaller than the average company (£1.6m)
- London Rheumatology Limited
£1.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -6%, show it is growing at a slower rate (6.4%)
- London Rheumatology Limited
6.4% - Industry AVG
Production
with a gross margin of 41.3%, this company has a comparable cost of product (41.3%)
- London Rheumatology Limited
41.3% - Industry AVG
Profitability
an operating margin of 25.6% make it more profitable than the average company (6.5%)
- London Rheumatology Limited
6.5% - Industry AVG
Employees
with 3 employees, this is below the industry average (17)
3 - London Rheumatology Limited
17 - Industry AVG
Pay Structure
on an average salary of £28.1k, the company has an equivalent pay structure (£28.1k)
- London Rheumatology Limited
£28.1k - Industry AVG
Efficiency
resulting in sales per employee of £92.7k, this is more efficient (£73.7k)
- London Rheumatology Limited
£73.7k - Industry AVG
Debtor Days
it gets paid by customers after 72 days, this is later than average (42 days)
- London Rheumatology Limited
42 days - Industry AVG
Creditor Days
its suppliers are paid after 4 days, this is quicker than average (31 days)
- London Rheumatology Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- London Rheumatology Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 527 weeks, this is more cash available to meet short term requirements (42 weeks)
527 weeks - London Rheumatology Limited
42 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.4%, this is a lower level of debt than the average (57.1%)
5.4% - London Rheumatology Limited
57.1% - Industry AVG
london rheumatology limited Credit Report and Business Information
London Rheumatology Limited Competitor Analysis
Perform a competitor analysis for london rheumatology limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
london rheumatology limited Ownership
LONDON RHEUMATOLOGY LIMITED group structure
London Rheumatology Limited has no subsidiary companies.
Ultimate parent company
LONDON RHEUMATOLOGY LIMITED
07052166
london rheumatology limited directors
London Rheumatology Limited currently has 2 directors. The longest serving directors include Ms Carolyn Axford (Oct 2009) and Mr John Axford (Oct 2009).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Carolyn Axford | England | 72 years | Oct 2009 | - | Director |
Mr John Axford | 70 years | Oct 2009 | - | Director |
LONDON RHEUMATOLOGY LIMITED financials
London Rheumatology Limited's latest turnover from October 2022 is estimated at £278.2 thousand and the company has net assets of £683.3 thousand. According to their latest financial statements, London Rheumatology Limited has 3 employees and maintains cash reserves of £393.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||
Other Income Or Grants | |||||||||||||
Cost Of Sales | |||||||||||||
Gross Profit | |||||||||||||
Admin Expenses | |||||||||||||
Operating Profit | |||||||||||||
Interest Payable | |||||||||||||
Interest Receivable | |||||||||||||
Pre-Tax Profit | |||||||||||||
Tax | |||||||||||||
Profit After Tax | |||||||||||||
Dividends Paid | |||||||||||||
Retained Profit | |||||||||||||
Employee Costs | |||||||||||||
Number Of Employees | 3 | 4 | 4 | 4 | 2 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 5,055 | 6,195 | 8,559 | 7,316 | 99,795 | 49,904 | 7,359 | 6,125 | 6,329 | 4,822 | 3,795 | 2,213 | 1,564 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 90,862 | 90,862 | 90,862 | 90,862 | 0 | 0 | 40,862 | 40,862 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 95,917 | 97,057 | 99,421 | 98,178 | 99,795 | 49,904 | 48,221 | 46,987 | 6,329 | 4,822 | 3,795 | 2,213 | 1,564 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 54,989 | 43,018 | 35,463 | 55,324 | 484,284 | 502,445 | 218,915 | 299,515 | 277,819 | 116,285 | 75,937 | 57,557 | 51,706 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 142,779 | 137,479 | 131,949 | 129,831 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 393,718 | 376,934 | 305,371 | 297,681 | 0 | 0 | 206,979 | 57,788 | 100,126 | 165,587 | 168,343 | 77,863 | 103,499 |
misc current assets | 34,629 | 34,629 | 34,629 | 34,629 | 6,093 | 5,685 | 6,519 | 6,614 | 24,714 | 19,358 | 12,202 | 0 | 0 |
total current assets | 626,115 | 592,060 | 507,412 | 517,465 | 490,377 | 508,130 | 432,413 | 363,917 | 402,659 | 301,230 | 256,482 | 135,420 | 155,205 |
total assets | 722,032 | 689,117 | 606,833 | 615,643 | 590,172 | 558,034 | 480,634 | 410,904 | 408,988 | 306,052 | 260,277 | 137,633 | 156,769 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 1,938 | 1,174 | 0 | 4,796 | 89,427 | 47,739 | 117,796 | 104,496 | 74,632 | 79,009 | 63,441 | 57,685 | 56,282 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 88,906 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 36,839 | 69,352 | 95,875 | 125,665 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 38,777 | 70,526 | 95,875 | 130,461 | 89,427 | 136,645 | 117,796 | 104,496 | 74,632 | 79,009 | 63,441 | 57,685 | 56,282 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 10,668 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 3,369 | 1,225 | 1,266 | 964 | 759 | 443 | 328 |
total long term liabilities | 0 | 0 | 0 | 0 | 9,309 | 10,668 | 3,369 | 1,225 | 1,266 | 964 | 759 | 443 | 328 |
total liabilities | 38,777 | 70,526 | 95,875 | 130,461 | 98,736 | 147,313 | 121,165 | 105,721 | 75,898 | 79,973 | 64,200 | 58,128 | 56,610 |
net assets | 683,255 | 618,591 | 510,958 | 485,182 | 491,436 | 410,721 | 359,469 | 305,183 | 333,090 | 226,079 | 196,077 | 79,505 | 100,159 |
total shareholders funds | 683,255 | 618,591 | 510,958 | 485,182 | 491,436 | 410,721 | 359,469 | 305,183 | 333,090 | 226,079 | 196,077 | 79,505 | 100,159 |
Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||
Operating Profit | |||||||||||||
Depreciation | 1,873 | 2,364 | 2,464 | 2,820 | 2,095 | 2,417 | 2,060 | 1,674 | 1,042 | 736 | |||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Tax | |||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 17,271 | 13,085 | -17,743 | -299,129 | -18,161 | 283,530 | -80,600 | 21,696 | 161,534 | 40,348 | 18,380 | 5,851 | 51,706 |
Creditors | 764 | 1,174 | -4,796 | -84,631 | 41,688 | -70,057 | 13,300 | 29,864 | -4,377 | 15,568 | 5,756 | 1,403 | 56,282 |
Accruals and Deferred Income | -32,513 | -26,523 | -29,790 | 125,665 | -10,668 | 10,668 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | -3,369 | 2,144 | -41 | 302 | 205 | 316 | 115 | 328 |
Cash flow from operations | |||||||||||||
Investing Activities | |||||||||||||
capital expenditure | |||||||||||||
Change in Investments | 0 | 0 | 0 | 90,862 | 0 | -40,862 | 0 | 40,862 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||
Financing Activities | |||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | -88,906 | 88,906 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||
interest | |||||||||||||
cash flow from financing | |||||||||||||
cash and cash equivalents | |||||||||||||
cash | 16,784 | 71,563 | 7,690 | 297,681 | 0 | -206,979 | 149,191 | -42,338 | -65,461 | -2,756 | 90,480 | -25,636 | 103,499 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 16,784 | 71,563 | 7,690 | 297,681 | 0 | -206,979 | 149,191 | -42,338 | -65,461 | -2,756 | 90,480 | -25,636 | 103,499 |
P&L
October 2022turnover
278.2k
+1%
operating profit
71.2k
0%
gross margin
41.4%
-4.05%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
October 2022net assets
683.3k
+0.1%
total assets
722k
+0.05%
cash
393.7k
+0.04%
net assets
Total assets minus all liabilities
london rheumatology limited company details
company number
07052166
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
October 2009
age
15
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
62 stakes road, waterlooville, PO7 5NT
last accounts submitted
October 2022
london rheumatology limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to london rheumatology limited.
london rheumatology limited Companies House Filings - See Documents
date | description | view/download |
---|